Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery ...

An Austin biotech company is laying off a third of its staff following news that its primary drug candidate didn't produce ...

Morgan Stanley analyst Michael Ulz maintained a Hold rating on Vir Biotechnology (VIR – Research Report) today and set a price target of ...

Eric Joseph, an analyst from J.P. Morgan, maintained the Hold rating on Vir Biotechnology (VIR – Research Report). The associated price target ...

Trial underscores IROS's commitment to developing innovative therapies for unmet medical needs <li /> The study's success ...

Imagine having a digital carbon copy of yourself that physicians could use to predict long-term risks for disease, assess how your body may respond to treatment, and simulate surgeries in advance. A ...

Veeva share price has recently been battling concerns that Salesforce will become a more aggressive competitor and take ...

Cannabis has long been a controversial substance, particularly within the world of professional sports, where its use has ...

The gene neuropilin2 regulates inhibitory neuron migration and excitatory neuron connections, essential for balanced brain activity.

When the immune system is more intact and you are giving these treated cells, it makes sense to me that clinically, that ...

It’s more important to practice regularly than to sporadically do longer sessions. 20 minutes a day is a better bet than 60 ...

Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of ...